James A. Wells
University of California, San Francisco
H-index: 125
North America-United States
Top articles of James A. Wells
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma | Scientific Reports | Takahide Nejo Lin Wang Kevin K Leung Albert Wang Senthilnath Lakshmanachetty | 2024/3/16 |
Degradation of surface proteins using bispecific binding agent | 2024/1/25 | ||
Internalizing receptor-directed bispecific binding agent-ligand fusions for the degradation of target proteins | 2024/3/14 | ||
Covalent inhibition of pro-apoptotic BAX | Nature Chemical Biology | Matthew W McHenry Peiwen Shi Christina M Camara Daniel T Cohen T Justin Rettenmaier | 2024/1/17 |
Abstract LB237: PVRL2 suppresses antitumor immune responses through PVRIG-and TIGIT-independent pathways | Cancer Research | Jiuling Yang Li Wang James Byrnes Lisa Kirkemo Hannah Driks | 2024/4/5 |
Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α | bioRxiv | Corleone S Delaveris Sophie Kong Jeff Glasgow Rita P Loudermilk Lisa L Kirkemo | 2024 |
Oxidative cyclization reagents reveal tryptophan cation–π interactions | Nature | Xiao Xie Patrick J Moon Steven WM Crossley Amanda J Bischoff Dan He | 2024/3/6 |
PVRL2 Suppresses Antitumor Immunity through PVRIG-and TIGIT-independent Pathways | Cancer Immunology Research | Jiuling Yang Li Wang James R Byrnes Lisa L Kirkemo Hannah Driks | 2024/5/2 |
Discovery of VH domains that allosterically inhibit ENPP1 | Nature Chemical Biology | Paige E Solomon Colton J Bracken Jacqueline A Carozza Haoqing Wang Elizabeth P Young | 2024/1 |
Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies | 2024/3/26 | ||
Antibody discovery identifies regulatory mechanisms of protein arginine deiminase 4 | Nature Chemical Biology | Xin Zhou Sophie Kong Allison Maker Soumya G Remesh Kevin K Leung | 2024/2/2 |
Ldl receptor-directed bispecific binding agent-ligand fusions for the degradation of target proteins | 2024/3/21 | ||
Extracellular targeted protein degradation: an emerging modality for drug discovery | James A Wells Kaan Kumru | 2024/2 | |
A general approach for selection of epitope-directed binders to proteins | bioRxiv | Jie Zhou Chau Q Le Yun Zhang James A Wells | 2022/10/25 |
Multi-scale photocatalytic proximity labeling reveals cell surface neighbors on and between cells | bioRxiv | Zhi Lin Kaitlin Schaefer Irene Lui Zi Yao Andrea A Fossati | 2023 |
Detection assay for sars-cov-2 virus | 2023/6/8 | ||
Secreted HLA-Fc fusion profiles immunopeptidome in hypoxic PDAC and cellular senescence | PNAS nexus | Nicholas J Rettko Lisa L Kirkemo James A Wells | 2023/12 |
Transcobalamin Receptor Autoantibodies in Central Vitamin B12 Deficiency | medRxiv | John V Pluvinage Thomas Ngo Christopher M Bartley Aaron Bodansky Bonny D Alvarenga | 2023 |
Theranostic Targeting of CUB Domain–Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer | Clinical Cancer Research | Shalini Chopra Kai Trepka Sasank Sakhamuri Alberto Carretero-González Jun Zhu | 2023/4/3 |
Detection assay for anti-sars-cov-2 antibodies | 2023/9/21 |
